APA (7th ed.) Citation

Nency, Y. M., Sekartini, R., Wirahmadi, A., Maria, S., Farhanah, N., Hapsari, R., . . . Sari, R. M. Safety and immunogenicity of SARS-CoV-2 protein subunit recombinant vaccine (Indovac®) in healthy populations aged 18 years and above in Indonesia: A phase I, observer-blind, randomized, controlled study. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Nency, Yetty Movieta, et al. Safety and Immunogenicity of SARS-CoV-2 Protein Subunit Recombinant Vaccine (Indovac®) in Healthy Populations Aged 18 Years and Above in Indonesia: A Phase I, Observer-blind, Randomized, Controlled Study. Taylor & Francis Group.

MLA (9th ed.) Citation

Nency, Yetty Movieta, et al. Safety and Immunogenicity of SARS-CoV-2 Protein Subunit Recombinant Vaccine (Indovac®) in Healthy Populations Aged 18 Years and Above in Indonesia: A Phase I, Observer-blind, Randomized, Controlled Study. Taylor & Francis Group.